Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective
Istanbul Medical Journal · 2019
DOI: 10.4274/imj.galenos.2018.04657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Istanbul Medical Journal, 2019. Verfasst von Alper Gümüş und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gümüş, A., Düz, M. E., Coşkun, C., Velet, M., & Koldaş, M. (2019). Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal. https://doi.org/10.4274/imj.galenos.2018.04657
Vancouver
Gümüş A, Düz ME, Coşkun C, Velet M, Koldaş M. Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal. 2019. doi:10.4274/imj.galenos.2018.04657
BibTeX
@article{Gm2019,
author = {Gümüş, Alper and Düz, Muhammed Emin and Coşkun, Cihan and Velet, Mustafa and Koldaş, Macit},
title = {Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective},
journal = {Istanbul Medical Journal},
year = {2019},
doi = {10.4274/imj.galenos.2018.04657}
}
EUVIMED